Cybin Inc (CYBN) Return on Equity ROE from the fourth quarter 2025 to fourth quarter 2024 and annually, average high and low, overall ranking from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cybin Inc   (NYSEAMER: CYBN)

Cybin Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Cybin Inc in the fourth quarter 2025?
Cybin Inc recorded a cumulative net loss of $-87 million during 12 months ending in the fourth quarter 2025, resulting in a negative return on equity (ROE) of -45.1%.

Within the Major Pharmaceutical Preparations industry 177 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2025 from 2848 to 3353.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Mar 31 2024)
IV. Quarter
Y / Y Equity Change -18.75 % 527.03 % -18.75 % -18.75 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -87 -60 -60 -60 -60
Return On Equity (TTM) -45.1 % -29.51 % -38.42 % -36 % -33.86 %
CYBN's Total Ranking # 3353 # 2848 # # #
Equity (TTM) in Millions 182 224 182 182 224
Seq. Equity Change -18.75 % 23.07 % 0 % -18.75 % 527.03 %
Seq. Net Income Change - - - - -

Back to CYBN Management Effectiveness >> CYBN's 5 Years Annual ROE >> Compare CYBN ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 178
Sector # 425
Overall # 3353

Return On Equity Statistics
High Average Low
-26.75 %
-58.4 %
-100.75 %
(Mar 31 2024)   (Mar 31 2023)





CYBN Annual Return On Equity (Mar 31 2025)
2025		 (Mar 31 2024)
2024		 (Mar 31 2023)
2023		 (Mar 31 2021)
2022
Total Equity in Millions 182 224 36 69 0
Y / Y Equity Change -18.75 % 527.03 % -47.94 % - -
Net Income in Millions -87 -60 -36 -24 0
Y / Y Net Income Change - - - - -
Return On Equity -47.7 % -26.75 % -100.75 % -35.6 % -

Back to CYBN Management Effectiveness >> CYBN's 5 Years Annual ROE >> Compare CYBN ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CYBN's' Return on Equity at Yahoo Finance
CYBN's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CYBN's Competitors
Subscribers only: Roe for Cybin Inc 's Suppliers
Subscribers only: Return On Equity for CYBN's Customers




Companies with similar Return On Equity at Mar 31 2025, within Healthcare Sector ROE

Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.